OPQ’s Emerging Technology Program

OPQ’s Emerging Technology Program

To address concerns about FDA’s familiarity with industry’s use of newer technology, CDER’s Office of Pharmaceutical Quality (OPQ) created the Emerging Technology Program to promote the adoption of innovative approaches to pharmaceutical product design and manufacturing. Through the program, industry representatives can meet with Emerging Technology Team members to discuss, identify, and resolve potential technical and regulatory issues regarding the development and implementation of a novel technology prior to filing a regulatory submission.

For more information about this program, including contact information, click here.